Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Rheumatology

Symptoms and Look-Alikes: Is It Systemic Sclerosis?

At a Glance

Systemic sclerosis (SSc) is an autoimmune condition causing skin thickening and internal scarring. Early signs include Raynaud's phenomenon and puffy fingers. A doctor can distinguish SSc from look-alike conditions by checking for specific antibodies and internal organ damage.

Systemic Sclerosis (SSc) is a “great imitator.” Because it can affect so many different parts of the body, its symptoms often overlap with other conditions. Getting the right diagnosis involves distinguishing between the visible changes on your skin and the “invisible” changes happening inside, while ruling out conditions that look similar [1][2].

The Earliest Warning Signs

For many people, the first signs of SSc aren’t thickened skin, but rather subtle changes in the hands and blood vessels.

  • Raynaud’s Phenomenon: This is often the very first symptom. It causes fingers and toes to turn white, blue, and then red in response to cold or stress [3]. While many people have “primary” Raynaud’s (which is harmless), in SSc, it is “secondary” and caused by actual damage to small blood vessels [4].
  • Puffy Fingers: Known as the “edematous phase,” your fingers may look swollen, like sausages, especially in the morning [5]. This puffiness is a major “red flag” that the immune system is beginning to affect the soft tissues [6].
  • Telangiectasia: These are small, widened blood vessels that look like tiny red spots or mats on the face, chest, or hands [7].

Visible vs. Invisible Symptoms

SSc is more than skin deep. Doctors categorize symptoms into those we can see and those we can only feel or measure through testing.

Visible Symptoms

  • Skin Thickening: This typically starts on the fingers (sclerodactyly) and can spread to the arms, face, and trunk [7].
  • Digital Ulcers: These are painful open sores on the fingertips caused by poor blood flow [8].
  • Calcium Deposits (Calcinosis): Hard, white lumps that form under the skin, which can sometimes break through and leak a chalky substance [7].

Invisible Symptoms

  • Gastrointestinal (GI) Issues: SSc can cause the muscles of the digestive tract to weaken. This leads to severe acid reflux (heartburn), difficulty swallowing, and a feeling of being full after only a few bites of food (early satiety) [9][10].
  • Fatigue and Pain: Deep, soul-crushing fatigue is one of the most common “invisible” symptoms. It is not just being tired; it is a systemic exhaustion that impacts daily life [11].
  • Internal Scarring: Scarring can happen in the lungs (interstitial lung disease) or high blood pressure can develop in the lung’s arteries (pulmonary hypertension), which may first feel like shortness of breath during exercise [8].

What Else Could It Be? (The “Look-Alikes”)

Several conditions can mimic the skin thickening of SSc, but they require different treatments.

Condition How it differs from Systemic Sclerosis (SSc)
Morphea (Localized Scleroderma) Affects only patches of skin; does not involve internal organs or Raynaud’s phenomenon [2][12].
Eosinophilic Fasciitis Causes skin to look like an “orange peel” (peau d’orange) and often follows strenuous exercise. It affects deeper tissue but usually spares the fingers [1].
Scleromyxedema Characterized by tiny, firm, waxy bumps (papules) arranged in lines, often linked to an underlying blood protein abnormality [1][2].
Nephrogenic Systemic Fibrosis (NSF) A rare condition that causes skin thickening similar to SSc, but it is triggered by exposure to MRI contrast dye (gadolinium) in people who already have severe kidney disease [1].

The Rare Variant: “Sine Scleroderma”

It is possible to have systemic sclerosis without any skin thickening at all. This is called Systemic Sclerosis sine scleroderma (ssSSc) [8].

In these cases, the “visible” skin thickening is missing, but the “invisible” internal organ involvement—such as lung scarring, GI issues, or kidney problems—is present [13]. Diagnosis for this variant relies heavily on finding SSc-specific autoantibodies in the blood and seeing characteristic blood vessel changes during a nailfold capillaroscopy (a test where a doctor looks at the skin at the base of your fingernail under a microscope) [14][4].

Common questions in this guide

What are the earliest warning signs of systemic sclerosis?
The earliest warning signs typically involve your hands and blood vessels. You may experience Raynaud's phenomenon, where fingers turn white, blue, and red in the cold, as well as unexplained puffy or swollen fingers.
Why does systemic sclerosis cause severe heartburn and trouble swallowing?
Systemic sclerosis can weaken the muscles in your digestive tract. This leads to common invisible symptoms like severe acid reflux (heartburn), difficulty swallowing, and feeling full after eating only a small amount of food.
How can I tell the difference between systemic sclerosis and localized scleroderma (morphea)?
Localized scleroderma, also known as morphea, only affects patches of the skin. Unlike systemic sclerosis, it does not involve internal organs or cause Raynaud's phenomenon.
What is systemic sclerosis sine scleroderma?
Systemic sclerosis sine scleroderma is a rare variant of the disease where patients have internal organ involvement, such as lung scarring or digestive issues, but do not develop any visible skin thickening.
How do doctors definitively diagnose systemic sclerosis?
Doctors use a combination of methods, including a nailfold capillaroscopy to look for specific blood vessel damage under a microscope, and blood tests to check for specific autoantibodies that are unique to systemic sclerosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we perform a nailfold capillaroscopy to see if my Raynaud's phenomenon shows the 'SSc-pattern' of blood vessel damage?
  2. 2.How can we tell if my skin changes are localized scleroderma (morphea) or systemic sclerosis?
  3. 3.What specific blood tests (autoantibodies) will help distinguish between systemic sclerosis and its 'look-alikes'?
  4. 4.If I have systemic sclerosis 'sine scleroderma,' what kind of internal monitoring do I need for my lungs and heart?
  5. 5.How can we manage my 'invisible' symptoms like fatigue and gastrointestinal issues, even if my skin symptoms are mild?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Scleroderma and scleroderma-like syndromes.

    Romanowska-Próchnicka K, Dziewit M, Lesiak A, et al.

    Frontiers in immunology 2024; (15()):1351675 doi:10.3389/fimmu.2024.1351675.

    PMID: 38887288
  2. 2

    [Sclerosing skin diseases].

    Sticherling M

    Der Internist 2019; (60(8)):783-791 doi:10.1007/s00108-019-0643-2.

    PMID: 31292667
  3. 3

    Assessing digital vasculopathy in systemic sclerosis.

    Herrick AL

    Rheumatology (Oxford, England) 2026; (65(2)) doi:10.1093/rheumatology/keag081.

    PMID: 41689194
  4. 4

    Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.

    Hong C, Xiang L, Saffari SE, Low AH

    Journal of scleroderma and related disorders 2022; (7(2)):144-150 doi:10.1177/23971983221088460.

    PMID: 35585956
  5. 5

    Early diagnosis of systemic sclerosis, where do we stand today?

    Lepri G, Bellando Randone S, Matucci Cerinic M, Guiducci S

    Expert review of clinical immunology 2022; (18(1)):1-3 doi:10.1080/1744666X.2022.2015327.

    PMID: 35023438
  6. 6

    Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.

    van de Zande SC, Abdulle AE, Al-Adwi Y, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(13)) doi:10.3390/diagnostics13132160.

    PMID: 37443554
  7. 7

    Applying the ACR/EULAR Systemic Sclerosis Classification Criteria to the Spanish Scleroderma Registry Cohort.

    Sáez-Comet L, Simeón-Aznar CP, Pérez-Conesa M, et al.

    The Journal of rheumatology 2015; (42(12)):2327-31 doi:10.3899/jrheum.150144.

    PMID: 26472418
  8. 8

    Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.

    Lescoat A, Huang S, Carreira PE, et al.

    JAMA dermatology 2023; (159(8)):837-847 doi:10.1001/jamadermatol.2023.1729.

    PMID: 37378994
  9. 9

    Esophageal dysmotility in systemic sclerosis: Relationship with extra-gastrointestinal manifestations and complementary utility of thoracic imaging.

    Santos I, Marques-Gomes C, Diz-Lopes M, et al.

    Journal of scleroderma and related disorders 2025; 23971983251362586 doi:10.1177/23971983251362586.

    PMID: 40787593
  10. 10

    Patient-reported gastrointestinal involvement is associated with reduced quality of life and disability in systemic sclerosis.

    Kéringer P, Kovács KT, Nagy G, et al.

    Journal of scleroderma and related disorders 2025; 23971983251345284 doi:10.1177/23971983251345284.

    PMID: 40488215
  11. 11

    Pain and fatigue in systemic sclerosis: Practical strategies for non-pharmacological management.

    Bonomi F, El Aoufy K, Bellando Randone S, et al.

    Journal of scleroderma and related disorders 2025; 23971983251369577 doi:10.1177/23971983251369577.

    PMID: 41001251
  12. 12

    Paraneoplastic Scleroderma: Are There Any Clues?

    Jedlickova H, Durčanská V, Vašků V

    Acta dermatovenerologica Croatica : ADC 2016; (24(1)):78-80.

    PMID: 27149136
  13. 13

    A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways.

    Jimenez SA, Mendoza FA, Piera-Velazquez S

    Frontiers in immunology 2025; (16()):1551911 doi:10.3389/fimmu.2025.1551911.

    PMID: 40308583
  14. 14

    Systemic sclerosis sine scleroderma with atypical clinical course: a rare case report.

    Samha R, Ghaddar SA, Raya M, Alhadi SA

    Annals of medicine and surgery (2012) 2023; (85(11)):5656-5661 doi:10.1097/MS9.0000000000001266.

    PMID: 37915647

This page provides educational information about systemic sclerosis symptoms and similar conditions. It does not replace professional medical evaluation or diagnosis. Always consult a healthcare provider for proper testing and symptom management.

Get notified when new evidence is published on Systemic sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.